Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$7.18
52 Week High$10.85
52 Week Low$2.31
Average Volume (30 days)42.51K
Share Related Items
Market Cap$57.17M
Shares Outstanding5.35M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-833.3%
Financial Strength
Quick Ratio (MRQ)10.7
Current Ratio (MRQ)11.0
LT Debt/Capital (MRQ)0%
Total Debt/Equity (MRQ)0%
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)114.34
Price/Book (MRQ)2.54
Price/Cash Flow (TTM)(5.50)
Per Share Data
Earnings (TTM)($1.97)
Sales (TTM)$0.09
Book Value (MRQ)$4.20
Cash Flow (TTM)($2.18)
Cash (MRQ)$4.51
Management Effectiveness
Return on Equity (TTM)-54.2%
Return on Assets (TTM)-50.8%
Return on Investment (TTM)-55.8%
Gross Margin (TTM)--
EBIT Margin (TTM)--
Profit Margin (TTM)--